Abstract Background Paravalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter
Transcatheter heart valves technologies
Transcatheter heart valves technologies
Pre‐procedural nursing home length of stay and outcomes of transcatheter aortic valve replacement
Abstract Background Older adults with severe aortic stenosis (AS) may receive care in a nursing home (NH) prior to undergoing
Transcatheter heart valves technologies
Two‐year follow‐up of transcatheter aortic valve replacement in low‐risk patients with symptomatic severe bicuspid aortic valve stenosis
Abstract Background In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low‐risk patients
Transcatheter heart valves technologies
Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification
Abstract Aims We aimed to evaluate transcatheter mitral valve implantation (TMVI) using predominantly balloon‐expandable transcatheter heart valves (THV) in patients
Transcatheter heart valves technologies
Impact of Elevated Gradients After Transcatheter Aortic Valve Implantation for Degenerated Surgical Aortic Valve Bioprostheses
Abstract Background Elevated aortic valve gradients are common after transcatheter aortic valve implantation for degenerated surgical aortic valve replacement bioprostheses,
Transcatheter heart valves technologies
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement
Abstract Background Mitral regurgitation (MR) is frequent in patients with aortic stenosis (AS). Although primary MR is an established negative
Transcatheter heart valves technologies
Paravalvular leak closure after TAVI with plugs: A literature review with a specific focus on arterio‐arterial loop
Abstract More than mild paravalvular leak (PVL) following transcatheter aortic valve implantation (TAVI) is associated with a twofold increase in
Transcatheter heart valves technologies
CT-derived Epicardial Adipose Tissue Inflammation Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement
Abstract Purpose Inflammatory changes in epicardial (EAT) and pericardial adipose tissue (PAT) are associated with increased overall cardiovascular risk. Using
Transcatheter heart valves technologies
Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement
Abstract Background Transcatheter aortic valve replacement (TAVR) has become an established method of aortic stenosis treatment but suffers from the
Transcatheter heart valves technologies
Impact of Neighborhood Social Deprivation on Delays to Access for Transcatheter Aortic Valve Replacement: Wait‐Times and Clinical Consequences
Abstract Background Transcatheter aortic valve replacement (TAVR) has become the standard of care for severe aortic stenosis treatment. Exponential growth
